Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis
Introduction: Ustekinumab (UST) has been approved for the treatment of moderate-to-severe ulcerative colitis (UC). Real-world data showing the effectiveness and safety of UST are necessary to confirm the results of clinical trials for applicability in daily clinical practice. Although some studies h...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Karger Publishers
2023-06-01
|
| Serier: | Inflammatory Intestinal Diseases |
| Fag: | |
| Online adgang: | https://beta.karger.com/Article/FullText/531497 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
